124 related articles for article (PubMed ID: 36925278)
1. Single-cell HER2 quantification via instant signal amplification in microdroplets.
Liu X; Zhu Y; Li C; Fang Y; Chen J; Xu F; Lu Y; Shum PP; Liu Y; Wang G
Anal Chim Acta; 2023 Apr; 1251():340976. PubMed ID: 36925278
[TBL] [Abstract][Full Text] [Related]
2. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
[TBL] [Abstract][Full Text] [Related]
3. A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells.
Kao KJ; Tai CH; Chang WH; Yeh TS; Chen TC; Lee GB
Biosens Bioelectron; 2015 Jul; 69():272-9. PubMed ID: 25770459
[TBL] [Abstract][Full Text] [Related]
4. Combining fluorescence-based image segmentation and automated microfluidics for ultrafast cell-by-cell assessment of biomarkers for HER2-type breast carcinoma.
Migliozzi D; Nguyen HT; Gijs MAM
J Biomed Opt; 2018 Nov; 24(2):1-8. PubMed ID: 30484294
[TBL] [Abstract][Full Text] [Related]
5. Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients.
Onsum MD; Geretti E; Paragas V; Kudla AJ; Moulis SP; Luus L; Wickham TJ; McDonagh CF; MacBeath G; Hendriks BS
Am J Pathol; 2013 Nov; 183(5):1446-1460. PubMed ID: 24035511
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer.
Lottner C; Schwarz S; Diermeier S; Hartmann A; Knuechel R; Hofstaedter F; Brockhoff G
J Pathol; 2005 Apr; 205(5):577-84. PubMed ID: 15732132
[TBL] [Abstract][Full Text] [Related]
7. Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer.
Dupouy DG; Ciftlik AT; Fiche M; Heintze D; Bisig B; de Leval L; Gijs MA
Sci Rep; 2016 Feb; 6():20277. PubMed ID: 26856369
[TBL] [Abstract][Full Text] [Related]
8. Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α.
Ceran C; Cokol M; Cingoz S; Tasan I; Ozturk M; Yagci T
BMC Cancer; 2012 Oct; 12():450. PubMed ID: 23033967
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action.
DeFazio-Eli L; Strommen K; Dao-Pick T; Parry G; Goodman L; Winslow J
Breast Cancer Res; 2011 Apr; 13(2):R44. PubMed ID: 21496232
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomic analysis of HER2 normal and overexpressing MCF-7 breast cancer cells revealed proteomic changes accompanied with HER2 gene amplification.
Tang Y; Mackey J; Lai R; Ghosh S; Santos C; Graham K; Damaraju S; Pasdar M; Li L
J Proteomics; 2013 Oct; 91():200-9. PubMed ID: 23851309
[TBL] [Abstract][Full Text] [Related]
11. Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs.
Ciftlik AT; Lehr HA; Gijs MA
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5363-8. PubMed ID: 23479638
[TBL] [Abstract][Full Text] [Related]
12. An amplification strategy for detecting HER2 with a quasi-targeted proteomics approach coupled with aptamer-triggered hybridization chain reaction.
Bao J; Zhang W; Zhou W; Lv M; Lu C; Yu H
Talanta; 2020 Aug; 215():120918. PubMed ID: 32312461
[TBL] [Abstract][Full Text] [Related]
13. Sensitive determination of the human epidermal growth factor receptor 2 (HER2) by immuno-polymerase chain reaction with inductively coupled plasma-mass spectrometry detection.
Asensio AF; Sierra LM; Montes-Bayón M; Blanco-González E
Anal Chim Acta; 2019 Dec; 1090():39-46. PubMed ID: 31655644
[TBL] [Abstract][Full Text] [Related]
14. High-content, cell-by-cell assessment of HER2 overexpression and amplification: a tool for intratumoral heterogeneity detection in breast cancer.
Nguyen HT; Migliozzi D; Bisig B; de Leval L; Gijs MAM
Lab Invest; 2019 May; 99(5):722-732. PubMed ID: 30659272
[TBL] [Abstract][Full Text] [Related]
15. Immunoelectrochemical detection of the human epidermal growth factor receptor 2 (HER2) via gold nanoparticle-based rolling circle amplification.
Shen C; Liu S; Li X; Zhao D; Yang M
Mikrochim Acta; 2018 Nov; 185(12):547. PubMed ID: 30426312
[TBL] [Abstract][Full Text] [Related]
16. Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.
Furrer D; Jacob S; Caron C; Sanschagrin F; Provencher L; Diorio C
Diagn Pathol; 2013 Feb; 8():17. PubMed ID: 23379971
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence hydrogel array based on interfacial cation exchange amplification for highly sensitive microRNA detection.
Wu L; Wang Y; He R; Zhang Y; He Y; Wang C; Lu Z; Liu Y; Ju H
Anal Chim Acta; 2019 Nov; 1080():206-214. PubMed ID: 31409471
[TBL] [Abstract][Full Text] [Related]
18. Concomitant detection of HER2 protein and gene alterations by immunohistochemistry (IHC) and silver enhanced in situ hybridization (SISH) identifies HER2 positive breast cancer with and without gene amplification.
Varga Z; Tubbs RR; Moch H
PLoS One; 2014; 9(8):e105961. PubMed ID: 25153153
[TBL] [Abstract][Full Text] [Related]
19. Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers.
Lamy PJ; Fina F; Bascoul-Mollevi C; Laberenne AC; Martin PM; Ouafik L; Jacot W
Breast Cancer Res; 2011 Feb; 13(1):R15. PubMed ID: 21288332
[TBL] [Abstract][Full Text] [Related]
20. In vitro detection of human breast cancer cells (SK-BR3) using herceptin-conjugated liquid crystal microdroplets as a sensing platform.
Ding W; Gupta KC; Park SY; Kim YK; Kang IK
Biomater Sci; 2016 Oct; 4(10):1473-84. PubMed ID: 27533001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
